FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011248696> ?p ?o ?g. }

• W2011248696 endingPage "677" @default.
• W2011248696 startingPage "672" @default.
• W2011248696 abstract "<b>Background: </b> Essential tremor is most prevalent and most disabling in older patients. Additional therapies are required for patients with an inadequate response or intolerable side effects. In small trials, topiramate appeared to be beneficial in essential tremor. <b>Methods: </b> In this multicenter, double-blind, placebo-controlled, parallel-design trial, patients with moderate to severe essential tremor of the upper limbs were randomized to 24 weeks of treatment with placebo or topiramate (target dose, 400 mg/day) as monotherapy or as an adjunct to one antitremor medication. The primary efficacy variable was the final visit tremor score based on the Fahn–Tolosa–Marin Tremor Rating Scale (TRS). <b>Results: </b> The intent-to-treat population was 208 patients (topiramate, 108; placebo, 100). The final visit score (last observation carried forward) was lower in the topiramate group than with placebo (<i>p</i> < 0.001). Mean percentage improvement in overall TRS scores was 29% with topiramate at a mean final dose of 292 mg/day and 16% with placebo (<i>p</i> < 0.001). Topiramate was associated with greater improvement in function and disability (<i>p</i> = 0.001). A between-group difference (<i>p</i> < 0.001) was observed at the first on-treatment visit at 4 weeks when the target topiramate dose was 100 mg/day (mean achieved dose, 62 ± 9 mg/day). The most common treatment-limiting adverse events in topiramate-treated patients were paresthesia (5%), nausea (3%), concentration/attention difficulty (3%), and somnolence (3%). Adverse events were treatment limiting in 31.9% of topiramate patients and 9.5% of placebo patients. <b>Conclusions: </b> Topiramate was effective in the treatment of moderate to severe essential tremor. Tremor reduction was accompanied by functional improvements, such as in motor tasks, writing, and speaking." @default.
• W2011248696 created "2016-06-24" @default.
• W2011248696 creator A5004708688 @default.
• W2011248696 creator A5005279477 @default.
• W2011248696 creator A5009117789 @default.
• W2011248696 creator A5009268096 @default.
• W2011248696 creator A5044027900 @default.
• W2011248696 creator A5055948025 @default.
• W2011248696 creator A5068655451 @default.
• W2011248696 creator A5071000356 @default.
• W2011248696 creator A5082443513 @default.
• W2011248696 creator A5086726410 @default.
• W2011248696 date "2006-01-25" @default.
• W2011248696 modified "2023-09-27" @default.
• W2011248696 title "Topiramate in essential tremor: A double-blind, placebo-controlled trial" @default.
• W2011248696 cites W1919431199 @default.
• W2011248696 cites W1923643286 @default.
• W2011248696 cites W1973511428 @default.
• W2011248696 cites W2009997148 @default.
• W2011248696 cites W2034278159 @default.
• W2011248696 cites W2037338708 @default.
• W2011248696 cites W2053338731 @default.
• W2011248696 cites W2061004160 @default.
• W2011248696 cites W2062526596 @default.
• W2011248696 cites W2063380813 @default.
• W2011248696 cites W2067753412 @default.
• W2011248696 cites W2068850255 @default.
• W2011248696 cites W2086178644 @default.
• W2011248696 cites W2109349806 @default.
• W2011248696 cites W2133508641 @default.
• W2011248696 doi "https://doi.org/10.1212/01.wnl.0000200779.03748.0f" @default.
• W2011248696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16436648" @default.
• W2011248696 hasPublicationYear "2006" @default.
• W2011248696 type Work @default.
• W2011248696 sameAs 2011248696 @default.
• W2011248696 citedByCount "156" @default.
• W2011248696 countsByYear W20112486962012 @default.
• W2011248696 countsByYear W20112486962013 @default.
• W2011248696 countsByYear W20112486962014 @default.
• W2011248696 countsByYear W20112486962015 @default.
• W2011248696 countsByYear W20112486962016 @default.
• W2011248696 countsByYear W20112486962017 @default.
• W2011248696 countsByYear W20112486962018 @default.
• W2011248696 countsByYear W20112486962019 @default.
• W2011248696 countsByYear W20112486962020 @default.
• W2011248696 countsByYear W20112486962021 @default.
• W2011248696 countsByYear W20112486962022 @default.
• W2011248696 countsByYear W20112486962023 @default.
• W2011248696 crossrefType "journal-article" @default.
• W2011248696 hasAuthorship W2011248696A5004708688 @default.
• W2011248696 hasAuthorship W2011248696A5005279477 @default.
• W2011248696 hasAuthorship W2011248696A5009117789 @default.
• W2011248696 hasAuthorship W2011248696A5009268096 @default.
• W2011248696 hasAuthorship W2011248696A5044027900 @default.
• W2011248696 hasAuthorship W2011248696A5055948025 @default.
• W2011248696 hasAuthorship W2011248696A5068655451 @default.
• W2011248696 hasAuthorship W2011248696A5071000356 @default.
• W2011248696 hasAuthorship W2011248696A5082443513 @default.
• W2011248696 hasAuthorship W2011248696A5086726410 @default.
• W2011248696 hasConcept C118552586 @default.
• W2011248696 hasConcept C126322002 @default.
• W2011248696 hasConcept C142724271 @default.
• W2011248696 hasConcept C197934379 @default.
• W2011248696 hasConcept C204787440 @default.
• W2011248696 hasConcept C27081682 @default.
• W2011248696 hasConcept C2777683783 @default.
• W2011248696 hasConcept C2778186239 @default.
• W2011248696 hasConcept C2779034229 @default.
• W2011248696 hasConcept C2780112193 @default.
• W2011248696 hasConcept C2780580376 @default.
• W2011248696 hasConcept C2908647359 @default.
• W2011248696 hasConcept C42219234 @default.
• W2011248696 hasConcept C71924100 @default.
• W2011248696 hasConcept C99454951 @default.
• W2011248696 hasConceptScore W2011248696C118552586 @default.
• W2011248696 hasConceptScore W2011248696C126322002 @default.
• W2011248696 hasConceptScore W2011248696C142724271 @default.
• W2011248696 hasConceptScore W2011248696C197934379 @default.
• W2011248696 hasConceptScore W2011248696C204787440 @default.
• W2011248696 hasConceptScore W2011248696C27081682 @default.
• W2011248696 hasConceptScore W2011248696C2777683783 @default.
• W2011248696 hasConceptScore W2011248696C2778186239 @default.
• W2011248696 hasConceptScore W2011248696C2779034229 @default.
• W2011248696 hasConceptScore W2011248696C2780112193 @default.
• W2011248696 hasConceptScore W2011248696C2780580376 @default.
• W2011248696 hasConceptScore W2011248696C2908647359 @default.
• W2011248696 hasConceptScore W2011248696C42219234 @default.
• W2011248696 hasConceptScore W2011248696C71924100 @default.
• W2011248696 hasConceptScore W2011248696C99454951 @default.
• W2011248696 hasIssue "5" @default.
• W2011248696 hasLocation W20112486961 @default.
• W2011248696 hasLocation W20112486962 @default.
• W2011248696 hasOpenAccess W2011248696 @default.
• W2011248696 hasPrimaryLocation W20112486961 @default.
• W2011248696 hasRelatedWork W1994499333 @default.
• W2011248696 hasRelatedWork W1998338808 @default.
• W2011248696 hasRelatedWork W2011248696 @default.
• W2011248696 hasRelatedWork W2096168305 @default.

• next